Arabic Arabic English English French French German German
dark

Labcorp Completes Acquisition of Myriad Autoimmune’s Vectra Testing Business

Labcorp today announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra ® rheumatoid arthritis (RA) assay. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Relief Therapeutics Provides Update on Regulatory Interactions in the United Kingdom and European Union Relating to Lead Drug Candidate, RLF-100 (Aviptadil)

Next Post

Ocular Therapeutix™ Updates Monthly In-Market Unit Sales of DEXTENZA® Billable Inserts

Related Posts
Total
0
Share